Skip to main content

Peer Review reports

From: An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa

Original Submission
22 Aug 2019 Submitted Original manuscript
18 Sep 2019 Author responded Author comments - Sivagurunathan Sutharsan
13 Dec 2019 Author responded Author comments - Sivagurunathan Sutharsan
Resubmission - Version 2
18 Sep 2019 Submitted Manuscript version 2
20 Jan 2020 Reviewed Reviewer Report - Katherine O'Neill
26 Jan 2020 Reviewed Reviewer Report - Tanja Pressler
29 Jan 2020 Reviewed Reviewer Report - Anders Lindblad
5 Mar 2020 Author responded Author comments - Sivagurunathan Sutharsan
Resubmission - Version 3
5 Mar 2020 Submitted Manuscript version 3
18 Mar 2020 Reviewed Reviewer Report - Katherine O'Neill
15 May 2020 Author responded Author comments - Sivagurunathan Sutharsan
Resubmission - Version 4
15 May 2020 Submitted Manuscript version 4
26 May 2020 Author responded Author comments - Sivagurunathan Sutharsan
Resubmission - Version 5
26 May 2020 Submitted Manuscript version 5
Publishing
28 May 2020 Editorially accepted
12 Jun 2020 Article published 10.1186/s12890-020-01201-y

You can find further information about peer review here.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us